Nature Reviews Drug Discovery



Reshma Kewalramani ()

>> Read More

Cracking KRAS ()

>> Read More

Synthetic lethality as an engine for cancer drug target discovery ()

>> Read More

Cloud-based data systems in drug regulation: an industry perspective ()

>> Read More

T<sub>reg</sub> conversion dampens autoimmunity ()

>> Read More

Double boost for mRNA cancer vaccines ()

>> Read More

NIH launches open science Alzheimer initiative ()

>> Read More

Arvinas’s PROTACs pass first safety and PK analysis ()

>> Read More